MPT Q1 2026 Earnings EPS Surges Past Estimates Yet Shares Edge Lower Compass Therapeutics Q1 2026 Earnings Narrowed Loss and Positive Surprise as Pipeline Progress Continues Immunovant Q1 2026 Earnings WiderThanExpected Loss as Pipeline Investment Continues Cartesian Therapeutics Inc RNAC Q1 2026 Earnings ClinicalStage Biotech Reports WiderThanExpected Loss Stock Ticks Higher Rio Tinto Q4 2025 Earnings EPS Misses Estimates Amid Challenging Commodity Environment UBFO Q4 2025 Earnings Reported EPS of 019 Stock Unchanged After Release